Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Small Cell Lung Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Mesothelioma 1Medulloblastoma 1Familial ependymoma 1Fallopian Tube Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

Filgrastim 4Cyclophosphamide 4Vincristine 3Topotecan 3Melphalan 3Lomustine 3Granulocyte Colony-Stimulating Factor 3Cisplatin 3etoposide phosphate 2Thiotepa 2Temozolomide 2Radiotherapy 2Mesna 2Ifosfamide 2Etoposide 2Carboplatin 2Busulfan 2sonidegib 1sodium thiosulfate 1silmitasertib 1sargramostim 1ribociclib 1poly ICLC 1palbociclib 1omburtamab I-131 1gadobutrol 1gadobenic acid 1bempegaldesleukin 1Yoga 1Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Medulloblastoma × Acetylcysteine × Clear all
NCT00238173 2017-04-21

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

OHSU Knight Cancer Institute

Phase 1 Terminated
2 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Optic Nerve Glioma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡